Research and Markets (http://www.researchandmarkets.com/research/3njfz2/clinical_imaging) has announced the addition of the "Clinical Imaging: Market and Outsourcing Dynamics" report to their offering.
Clinical imaging has become an integral part of the extensive and expensive research and development process of the pharmaceutical and biotechnology industries. Clinical imaging modalities such as magnetic resonance images (MRI), computed topography scans (CT), and x-rays are fundamental in testing the safety and efficacy of drugs in development phases I through IV.
This report offers two unique perspectives to the clinical imaging service provider market based on the surveys ISR has administered - one from the perspective of companies who currently outsource their imaging services and another from the actual imaging service providers.
Key Topics Covered:
1. Introduction
2. Report benefits
3. Report sections
4. Methodology and sources
5. Executive Summary
6. Demographics & responsibilities of respondents outsourcing imaging services
7. Perspectives on outsourcing imaging services
8. Experiences & practices of companies outsourcing imaging services
9. Current use of imaging within clinical trials
10. Service provider capabilities
11. Company Profiles
For more information visit http://www.researchandmarkets.com/research/3njfz2/clinical_imaging.
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
